Truhn, Daniel http://orcid.org/0000-0002-9605-0728
Eckardt, Jan-Niklas
Ferber, Dyke http://orcid.org/0009-0006-6195-9276
Kather, Jakob Nikolas
Article History
Received: 21 September 2023
Accepted: 12 March 2024
First Online: 22 March 2024
Competing interests
: J.N.K. declares consulting services for Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; Scailyte, Switzerland; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI GmbH, Germany, has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Eisai, Janssen, MSD, BMS, Roche, Pfizer and Fresenius. Furthermore, J.N.K. is a Deputy Editor at npj Precision Oncology. J.-N.E. declares research funding from Novartis Oncology, honoraria from Janssen, AstraZeneca, Amgen, and co-ownership of Cancilico GmbH. No other potential conflicts of interest are disclosed by any of the authors.